The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-[(5-Fluoro-2-hydroxy-3-propylphenyl)methylene]-4-[[4-(trifluoromethyl)phenyl]methyl]-1-piperazineacetohydrazide ID: ALA3426443
Chembl Id: CHEMBL3426443
PubChem CID: 136510228
Max Phase: Preclinical
Molecular Formula: C24H28F4N4O2
Molecular Weight: 480.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1cc(F)cc(/C=N/NC(=O)CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c1O
Standard InChI: InChI=1S/C24H28F4N4O2/c1-2-3-18-12-21(25)13-19(23(18)34)14-29-30-22(33)16-32-10-8-31(9-11-32)15-17-4-6-20(7-5-17)24(26,27)28/h4-7,12-14,34H,2-3,8-11,15-16H2,1H3,(H,30,33)/b29-14+
Standard InChI Key: SSLAZDHKHSZJAX-IPPBACCNSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 480.51Molecular Weight (Monoisotopic): 480.2148AlogP: 3.77#Rotatable Bonds: 8Polar Surface Area: 68.17Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 8.81CX Basic pKa: 6.86CX LogP: 4.60CX LogD: 4.56Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.66
References 1. Roth HS, Botham RC, Schmid SC, Fan TM, Dirikolu L, Hergenrother PJ.. (2015) Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics., 58 (9): [PMID:25856364 ] [10.1021/acs.jmedchem.5b00413 ]